Corbus Pharmaceuticals stock holds at USD 1.56

Corbus Pharmaceuticals stock (ISIN US21833E1038) closed at USD 1.56 on Nasdaq on September 21, 2026, down USD 0.05 from the prior close. The quote snapshot also recorded an intraday high of USD 1.6588, a low of USD 1.55 and volume of 70,018 shares.

Nasdaq trading sets the reference

The September 21, 2026 close provides the article's reference level because Corbus Pharmaceuticals is a US-listed issuer and the available market snapshot identifies Nasdaq as the trading venue. The session turnover was USD 111,686.83, calculated from the reported volume and quoted trading value.

The stock ended USD 0.05 below the reported opening price of USD 1.61, while the intraday spread between USD 1.55 and USD 1.6588 was USD 0.1088. That range shows a session with movement around the USD 1.60 level, but the available quote does not establish a broader trend.

Operating figures need a dated period

Corbus Pharmaceuticals operates in the biotechnology sector, where quarterly revenue, cash usage and clinical development milestones can materially change the investment case. A fundamental figure is meaningful only when it is tied to a named reporting period, so the September 21 market data remain the measurable anchor here.

For investors, the most concrete comparison in the available snapshot is the stock's USD 0.05 decline from the prior close against the USD 0.1088 high-to-low intraday spread on September 21, 2026. The close was USD 0.05 below the opening price and USD 0.0988 below the session high.

Stock remains near USD 1.60

Corbus Pharmaceuticals stock finished at USD 1.56 on September 21, 2026, on Nasdaq, with 70,018 shares traded. The next market session will determine whether the USD 1.55 low or the USD 1.6588 high becomes the nearer reference level.

More news and analyses on Corbus Pharmaceuticals stock